FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000998097> ?p ?o ?g. }

• W2000998097 endingPage "e90047" @default.
• W2000998097 startingPage "e90047" @default.
• W2000998097 abstract "A systematic review and meta-analysis was conducted to evaluate the efficacy and safety of macrolide therapy in adults and children with bronchiectasis.We searched the PUBMED, EMBASE, CENTRAL databases to identify relevant studies. Two reviewers evaluated the studies and extracted data independently. The primary outcome was the number of bronchiectasis exacerbations. Secondary outcomes included exacerbation-related admissions, quality of life (QoL), spirometry, 6-minute walk test (6MWT) and adverse events.Nine eligible trials with 559 participants were included. Six were conducted on adults, and the remaining on children. Macrolide therapy significantly reduced the number of patients experiencing one or more exacerbation in adults [risk ratio (RR) = 0.59; 95% CI, 0.40 to 0.86; P = 0.006; I2 = 65%] and children [RR = 0.86; 95% CI, 0.75-0.99; P = 0.04; I2 = 0%], but not the number of patients with admissions for exacerbation. Macrolide therapy was also associated with reduced frequency of exacerbations in adults (RR = 0.42; 95% CI, 0.29 to 0.61; P<0.001; I2 = 64%) and children (RR = 0.50; 95% CI, 0.35 to 0.71; P<0.001). Pooled analyses suggested that spirometry, including FEV1 and FVC, were significantly improved in adults but not in children. Macrolide therapy improved the QoL (WMD, -6.56; 95% CI, -11.99 to -1.12; P = 0.02; I2 = 86%) but no significant difference in 6MWT (WMD, 4.15; 95% CI, -11.83 to 20.13; P = 0.61; I2 = 31%) and the overall adverse events (RR, 0.96; 95% CI, 0.82 to 1.13; P = 0.66; I2 = 0%) in adults. However, reports of diarrhea and abdominal discomforts were higher with macrolide therapy.Macrolide maintenance therapy, both in adults and children, was effective and safe in reducing bronchiectasis exacerbations, but not the admissions for exacerbations. In addition, macrolide administration in adults was associated with improvement in QoL and spirometry, but not 6WMT. Future studies are warranted to verify the optimal populations and clarify its potential effects on antimicrobial resistance." @default.
• W2000998097 created "2016-06-24" @default.
• W2000998097 creator A5011404538 @default.
• W2000998097 creator A5025968825 @default.
• W2000998097 creator A5028445419 @default.
• W2000998097 creator A5030381486 @default.
• W2000998097 creator A5033892670 @default.
• W2000998097 creator A5034499557 @default.
• W2000998097 creator A5043934458 @default.
• W2000998097 creator A5066257784 @default.
• W2000998097 creator A5076409986 @default.
• W2000998097 date "2014-03-06" @default.
• W2000998097 modified "2023-09-28" @default.
• W2000998097 title "Macrolide Therapy in Adults and Children with Non-Cystic Fibrosis Bronchiectasis: A Systematic Review and Meta-Analysis" @default.
• W2000998097 cites W1705408830 @default.
• W2000998097 cites W1974799836 @default.
• W2000998097 cites W1986215651 @default.
• W2000998097 cites W1995487477 @default.
• W2000998097 cites W1995560753 @default.
• W2000998097 cites W2000113801 @default.
• W2000998097 cites W2020236675 @default.
• W2000998097 cites W2037017598 @default.
• W2000998097 cites W2052903571 @default.
• W2000998097 cites W2059378575 @default.
• W2000998097 cites W2082263581 @default.
• W2000998097 cites W2096667163 @default.
• W2000998097 cites W2108506420 @default.
• W2000998097 cites W2111278241 @default.
• W2000998097 cites W2111407500 @default.
• W2000998097 cites W2112433656 @default.
• W2000998097 cites W2113501330 @default.
• W2000998097 cites W2119425860 @default.
• W2000998097 cites W2121246362 @default.
• W2000998097 cites W2126760050 @default.
• W2000998097 cites W2126930838 @default.
• W2000998097 cites W2131402575 @default.
• W2000998097 cites W2144443028 @default.
• W2000998097 cites W2148605433 @default.
• W2000998097 cites W2149284263 @default.
• W2000998097 cites W2150624189 @default.
• W2000998097 cites W2151355567 @default.
• W2000998097 cites W2163467593 @default.
• W2000998097 cites W2163761940 @default.
• W2000998097 cites W2165409221 @default.
• W2000998097 cites W2169216429 @default.
• W2000998097 cites W4234724309 @default.
• W2000998097 doi "https://doi.org/10.1371/journal.pone.0090047" @default.
• W2000998097 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3946068" @default.
• W2000998097 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24603554" @default.
• W2000998097 hasPublicationYear "2014" @default.
• W2000998097 type Work @default.
• W2000998097 sameAs 2000998097 @default.
• W2000998097 citedByCount "35" @default.
• W2000998097 countsByYear W20009980972015 @default.
• W2000998097 countsByYear W20009980972016 @default.
• W2000998097 countsByYear W20009980972017 @default.
• W2000998097 countsByYear W20009980972018 @default.
• W2000998097 countsByYear W20009980972019 @default.
• W2000998097 countsByYear W20009980972020 @default.
• W2000998097 countsByYear W20009980972021 @default.
• W2000998097 countsByYear W20009980972022 @default.
• W2000998097 countsByYear W20009980972023 @default.
• W2000998097 crossrefType "journal-article" @default.
• W2000998097 hasAuthorship W2000998097A5011404538 @default.
• W2000998097 hasAuthorship W2000998097A5025968825 @default.
• W2000998097 hasAuthorship W2000998097A5028445419 @default.
• W2000998097 hasAuthorship W2000998097A5030381486 @default.
• W2000998097 hasAuthorship W2000998097A5033892670 @default.
• W2000998097 hasAuthorship W2000998097A5034499557 @default.
• W2000998097 hasAuthorship W2000998097A5043934458 @default.
• W2000998097 hasAuthorship W2000998097A5066257784 @default.
• W2000998097 hasAuthorship W2000998097A5076409986 @default.
• W2000998097 hasBestOaLocation W20009980971 @default.
• W2000998097 hasConcept C126322002 @default.
• W2000998097 hasConcept C159110408 @default.
• W2000998097 hasConcept C187212893 @default.
• W2000998097 hasConcept C197934379 @default.
• W2000998097 hasConcept C2776042228 @default.
• W2000998097 hasConcept C2776938444 @default.
• W2000998097 hasConcept C2777014857 @default.
• W2000998097 hasConcept C2777714996 @default.
• W2000998097 hasConcept C2779379686 @default.
• W2000998097 hasConcept C2779951463 @default.
• W2000998097 hasConcept C2780333948 @default.
• W2000998097 hasConcept C44249647 @default.
• W2000998097 hasConcept C71924100 @default.
• W2000998097 hasConcept C82789193 @default.
• W2000998097 hasConcept C95190672 @default.
• W2000998097 hasConceptScore W2000998097C126322002 @default.
• W2000998097 hasConceptScore W2000998097C159110408 @default.
• W2000998097 hasConceptScore W2000998097C187212893 @default.
• W2000998097 hasConceptScore W2000998097C197934379 @default.
• W2000998097 hasConceptScore W2000998097C2776042228 @default.
• W2000998097 hasConceptScore W2000998097C2776938444 @default.
• W2000998097 hasConceptScore W2000998097C2777014857 @default.
• W2000998097 hasConceptScore W2000998097C2777714996 @default.
• W2000998097 hasConceptScore W2000998097C2779379686 @default.
• W2000998097 hasConceptScore W2000998097C2779951463 @default.

• next